Glickman Marc H. 4
4 · enVVeno Medical Corp · Filed Dec 2, 2021
Insider Transaction Report
Form 4
Glickman Marc H.
See Remarks
Transactions
- Award
Common Stock
2021-11-30+100,000→ 101,600 total - Award
Stock Options
2021-11-30+265,700→ 265,700 totalExercise: $6.70Exp: 2031-11-30→ Common Stock (265,700 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted 100,000 restricted stock units on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The restricted stock units are subject to milestone-based vesting as follows: (i) 50% upon SAVVE (Surgical Anti-reflux Venous Valve Endoprosthesis) endpoints being achieved, and (ii) 50% upon the Pre-Market Approval of the VenoValve.
- [F2]The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2024.